Our employees deserve the credit behind delivery of our stellar product and service offerings that enhance the lives of patients. Their dedication to this company and our vision has made it the Pentec we celebrate today.
Philadelphia, PA (PRWEB) October 23, 2012
Pentec Health has been presented with the Silver Life Sciences Company of the Year award by the Philadelphia Business Journal and Pennsylvania BIO. The Life Sciences of the Year awards are the Journal’s annual program recognizing the region's startup, research, and incubator companies whose work advances the science. Pentec's track record of financial performance and growth has been consistent and strong for several years. Inc. magazine recognized Pentec as one of the 5,000 fastest-growing private companies in America for the past three years, and revenue growth of more than 200 percent earned the company a Top 50 ranking in the region.
Pentec is being recognized for its significant growth, due in large part to the successful launch of its innovative proprietary renal nutrition product, Proplete®. Proplete is an Intradialytic Parenteral Nutrition (IDPN) solution uniquely formulated to restore blood proteins often depleted in chronic dialysis patients. Proplete has been attributed to enhancing the quality of life to thousands of patients, as well as averting tens of thousands of hospital stays, and saving millions of dollars in Medicare costs.
“We are proud and honored to be recognized by Pennsylvania BIO and Philadelphia Business Journal,” says Joe Cosgrove, Chairman, President and CEO. “Our employees deserve the credit behind delivery of our stellar product and service offerings that enhance the lives of patients. Their dedication to this company and our vision has made it the Pentec we celebrate today.”
For nearly 30 years, Pentec has been a leading specialty infusion pharmacy focused on providing innovative and proprietary nutritional therapies for patients suffering from chronic renal failure and highly complex therapies for patients with intrathecal pumps. The company operates two primary divisions, Renal and Specialty Infusion. Pentec’s tremendous growth was fueled in 2008 when Mr. Cosgrove joined the company as President and CEO. His assessment of the company led to extensive changes that brought Pentec national status as a leader in the life sciences. In the last four years, Pentec has expanded its patient population; extended its national market; added to its employee base; and increased revenue.
About Pentec Health, Inc.
Pentec Health Inc. is a privately held specialty infusion services and healthcare technology company headquartered in suburban Philadelphia. Cutting edge innovations in patient care allow Pentec Health to provide products and services to underserved patient populations. The Joint Commission has consistently awarded Pentec with a Gold Seal of Approval for their commitment to providing the highest level of patient safety and patient care for renal nutritional and specialty infusion home care services. Pentec’s renal nutrition business specializes in providing patient-specific, proprietary nutritional therapies for patients suffering from chronic kidney disease. Pentec’s specialty infusion business provides in-home care for patients with implanted drug delivery pumps treating severe pain and/or spasticity. Pentec’s award-winning executives are noted for top leadership and giving back to the communities in which they serve. For more information, visit http://www.pentechealth.com